JP2004524806A5 - - Google Patents

Download PDF

Info

Publication number
JP2004524806A5
JP2004524806A5 JP2002507992A JP2002507992A JP2004524806A5 JP 2004524806 A5 JP2004524806 A5 JP 2004524806A5 JP 2002507992 A JP2002507992 A JP 2002507992A JP 2002507992 A JP2002507992 A JP 2002507992A JP 2004524806 A5 JP2004524806 A5 JP 2004524806A5
Authority
JP
Japan
Prior art keywords
cells
cell
chimeric protein
seq
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002507992A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004524806A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/020946 external-priority patent/WO2002002751A2/en
Publication of JP2004524806A publication Critical patent/JP2004524806A/ja
Publication of JP2004524806A5 publication Critical patent/JP2004524806A5/ja
Pending legal-status Critical Current

Links

JP2002507992A 2000-06-30 2001-07-02 新しい機能のための細胞膜の変更 Pending JP2004524806A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21558000P 2000-06-30 2000-06-30
PCT/US2001/020946 WO2002002751A2 (en) 2000-06-30 2001-07-02 Alteration of cell membrane

Publications (2)

Publication Number Publication Date
JP2004524806A JP2004524806A (ja) 2004-08-19
JP2004524806A5 true JP2004524806A5 (cg-RX-API-DMAC7.html) 2008-08-07

Family

ID=22803538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002507992A Pending JP2004524806A (ja) 2000-06-30 2001-07-02 新しい機能のための細胞膜の変更

Country Status (7)

Country Link
US (4) US7238360B2 (cg-RX-API-DMAC7.html)
EP (1) EP1299522B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004524806A (cg-RX-API-DMAC7.html)
AT (1) ATE531789T1 (cg-RX-API-DMAC7.html)
AU (2) AU2002216763B2 (cg-RX-API-DMAC7.html)
CA (1) CA2413237C (cg-RX-API-DMAC7.html)
WO (1) WO2002002751A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927602B2 (en) * 2002-07-23 2011-04-19 University Of Louisville Research Foundation, Inc. Fas ligand-avidin/streptavidin fusion proteins
ATE531789T1 (de) * 2000-06-30 2011-11-15 Univ Louisville Res Found Zellmembranenveränderung
US9321992B2 (en) 2002-06-14 2016-04-26 Case Western Reserve University Cell targeting methods and compositions
US7373559B2 (en) * 2003-09-11 2008-05-13 Copan Systems, Inc. Method and system for proactive drive replacement for high availability storage systems
WO2006119121A2 (en) * 2005-04-29 2006-11-09 University Of Louisville Research Foundation, Inc. Cell-surface decoration with active agents
DK1907000T4 (da) 2005-06-08 2020-03-30 The President And Fellows Of Harvard College Fremgangsmåder og sammensætninger til behandling af persisterende HIV-infektioner ved hæmning af reaktionsvejen for programmeret celledød 1 (PD-1).
EP1973572A2 (en) * 2005-12-08 2008-10-01 University of Louisville Research Foundation, Inc. In vivo cell surface engineering
WO2007067683A2 (en) * 2005-12-08 2007-06-14 University Of Louisville Research Foundation, Inc. Methods and compositions for expanding t regulatory cells
WO2007123636A2 (en) * 2006-03-27 2007-11-01 Children's Hospital & Regional Medical Center Compositions and methods comprising the use of cell surface displayed homing endonucleases
CA2673870A1 (en) * 2006-12-27 2008-07-10 Emory University Compositions and methods for the treatment of infections and tumors
MX2011005691A (es) * 2008-11-28 2011-07-20 Univ Emory Metodos para el tratamiento de infecciones y tumores.
EP2595637B1 (en) * 2010-07-22 2017-11-01 Cellect Biotherapeutics Ltd. Regulatory immune cells with enhanced targeted cell death effect
WO2016205714A1 (en) * 2015-06-19 2016-12-22 University Of Louisville Research Foundation, Inc. Immunomodulation for the long term prevention and treatment of autoimmune diseases and foreign tissue rejection
EP3828266B1 (en) 2015-07-29 2022-11-23 ONK Therapeutics Limited Modified natural killer cells and natural killer cell lines having increased cytotoxicity
US10906951B2 (en) 2015-07-29 2021-02-02 Onk Therapeutics Limited Modified natural killer cells and natural killer cell lines having increased cytotoxicity
HUE064306T2 (hu) * 2017-03-10 2024-02-28 Univ Louisville Res Found Inc FasL-módosított bioanyagok immunmodulátor funkcióval
AU2018336787B2 (en) 2017-09-19 2024-05-30 Corflow Therapeutics Ag Intracoronary characterization of microvascular obstruction (MVO) and myocardial infarction
ES3013122T3 (en) 2018-04-27 2025-04-11 Aimed Bio Inc Magnetic-based biopanning method through attachment of magnetic bead to cell
US11504335B2 (en) 2018-06-18 2022-11-22 University Of Kentucky Research Foundation Increased cell retention in diseased site when cells encapsulated in gelatin methacrylate and polyethylene glycol diacrylate hydrogels
EP4792852A2 (en) 2020-05-22 2026-08-19 CorFlow Therapeutics AG Controlled flow infusion microvascular dysfunction diagnostic and therapy

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2035868A1 (en) * 1989-07-06 1991-01-07 Richard C. Svrluga Hybrid molecules
US6071716A (en) * 1990-10-01 2000-06-06 Dana-Farber Cancer Institute DNA encoding, B7, a new member of the IG superfamily with unique expression on activated and neoplastic B cells
US5470701A (en) * 1993-02-24 1995-11-28 The Regents Of The University Of California Method for determining favorable prognosis in an HIV positive subject using HLA-DR+ /CD38- CD8bright cells
US6130316A (en) * 1993-07-26 2000-10-10 Dana Farber Cancer Institute Fusion proteins of novel CTLA4/CD28 ligands and uses therefore
US5858776A (en) * 1993-11-03 1999-01-12 Repligen Corporation Tumor cells with increased immunogenicity and uses therefor
US6218510B1 (en) * 1994-03-02 2001-04-17 Brigham & Woman's Hospital B7-1 and B7-2 polypeptides
CA2225378C (en) * 1995-06-29 2012-04-17 Immunex Corporation Cytokine that induces apoptosis
US6004942A (en) * 1995-08-30 1999-12-21 The Regents Of The University Of California Methods for treating arthritis by administering an apoptosis regulator
GB9523469D0 (en) 1995-11-16 1996-01-17 Sandoz Ltd Organic compounds
AU2527397A (en) * 1996-03-13 1997-10-01 Protein Design Labs, Inc. Fas ligand fusion proteins and their uses
US6060054A (en) * 1996-04-10 2000-05-09 National Jewish Medical And Research Center Product for T lymphocyte immunosuppression
WO1998020896A1 (en) * 1996-11-15 1998-05-22 Health Research Inc. A method for inducing apoptosis of primary central nervous system b cell lymphomas
GB9721075D0 (en) * 1997-10-03 1997-12-03 Cancer Res Campaign Tech Materials and methods relating to the stimulation of cells
US7144991B2 (en) * 1999-06-07 2006-12-05 Aletheon Pharmaceuticals, Inc. Streptavidin expressed gene fusions and methods of use thereof
JP2003517311A (ja) 1999-12-16 2003-05-27 ユニバーシティ オブ ルイビル リサーチ ファウンデーション,インコーポレイティド カスパーゼにより誘導されるアポトーシスのための組成物および方法
US7927602B2 (en) * 2002-07-23 2011-04-19 University Of Louisville Research Foundation, Inc. Fas ligand-avidin/streptavidin fusion proteins
DE60143074D1 (de) 2000-01-24 2010-10-28 Univ Louisville Res Found Immunmodulation mit rezeptorinduziertem tod durch apoptosis
ATE531789T1 (de) 2000-06-30 2011-11-15 Univ Louisville Res Found Zellmembranenveränderung
WO2007067683A2 (en) * 2005-12-08 2007-06-14 University Of Louisville Research Foundation, Inc. Methods and compositions for expanding t regulatory cells
EP1973572A2 (en) * 2005-12-08 2008-10-01 University of Louisville Research Foundation, Inc. In vivo cell surface engineering

Similar Documents

Publication Publication Date Title
JP4568907B2 (ja) 免疫賦活オリゴヌクレオチド及びその使用
Weber et al. Clinical management of Lyme borreliosis
JP2001524320A5 (cg-RX-API-DMAC7.html)
JP2002542827A5 (cg-RX-API-DMAC7.html)
HU230702B1 (hu) Eljárás jopamidol előállítására
EP1052286A3 (en) Growth hormone and growth hormone releasing hormone compositions
JP2005512518A5 (cg-RX-API-DMAC7.html)
Wulf et al. An old sweet song.
Gorman et al. Battling the AIDS virus.
Fricker New asthma drug proves useful in young children.
Gorman et al. The odds grow longer.
Majnarich Method for preparing a purified extraction residue fraction and its use in stimulating the immune response
Butcher Wake-up call for sleep-inducing neurons.
Gibbs et al. LIFE ALONG THE MISSISSIPPI.
Kumar Last chance'to control tuberculosis in India.
Farley et al. Just in case you hadn't heard--the'60s are over.
Handy Have gigabytes, will act.
McIntyre et al. Immunisation in the age of the human genome
Barovick et al. It's Beginning to Sound A Lot Like Christmas Past.
Howard et al. Shot Through The Heart.
Dulles The church and the universal catechism.
Featherstone Chaperoning tumour antigens into the immune system.
Golden Not Just for Prevention Anymore.
Howard et al. Crack cars.
Howard et al. Coming to Broadway, Direct From the Multiplex.